Dr. Banta-Green studies substance use involving opioids and stimulants and interventions to support recovery and reduce substance-related harms. He is particularly interested in developing interventions that are accessible to all people, including those who are most marginalized, such as those who are unhoused, utilizing services syringe service programs, and/or in the criminal legal system. He provides technical assistance and evaluation services for public health and safety interventions including the website http://stopoverdose.org, and information for the general public and professionals about effective treatments at http://learnabouttreatment.org. As an epidemiologist he develops innovative approaches to measuring the use and impacts of substances as well as service utilization. His health services research involves clinical trials, implementation research, and secondary data analyses. He serves on local, state, and federal workgroups and committees related to epidemiology, policy, and interventions for illicit substance-related problems. He is a member of the U.S. Health and Human Service’s Interdepartmental Substance Use Disorders Coordinating Committee.
Dr. Neuhaus has a broad research focus on social-emotional processes in individuals with neurodevelopmental disorders, particularly children with autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), or inherited or de novo genetic events. Dr. Neuhaus’s research is informed by a number of methodological approaches, including clinical/behavioral assessment and physiological measures such as EEG and autonomic biomarkers. Dr. Neuhaus is particularly interested in how social and emotional processes relate to brain function and development, and in how they interact with one another to influence diagnostic outcomes (e.g., phenotypes within autism) and psychiatric trajectories over the course of development. Clinically, Dr. Neuhaus specializes in diagnostic assessment of ASD.
I completed my adult psychiatry residency at the University of California, Davis and went on to complete my child & adolescent psychiatry fellowship at Seattle Children’s. My clinical work is focused on inpatient psychiatry and psychopharmacology. I have a particular interest in working with families and children in management of disruptive behavior disorders.
I am a clinical psychologist and researcher. My research focuses on pediatric psychology, intervention science, and leveraging digital technologies to disseminate and implement evidence-based psychosocial interventions for children, teens, and young adults with serious medical conditions and co-occurring anxiety, stress, and depression. Digital mental health care initiatives have the potential to scale-up interventions and overcome structural barriers and unequal access to psychosocial care. Current and future research investigations aim to help improve patient and family coping skills, psychosocial well-being, and quality of life by developing and implementing evidence-based mental health interventions.
Dr. Megan Goldenshteyn works as a licensed psychologist at the Institute on Human Development and Disability (IHDD) in the Child Development Clinic, Cardiac Neurodevelopment Clinic, Down Syndrome Specialty Clinic, and the Infant Development Follow-up Clinic. Dr. Goldenshteyn conducts psychological and developmental evaluations and supervises the psychology trainees, including the postdoctoral fellow and residents.
I am a child and adolescent psychiatrist at Seattle Children’s Hospital and faculty member at the University of Washington Medicine. My SCH practice locations include the Gender Clinic (Adolescent Medicine), Outpatient Psychiatry Clinic, Autism Center, and the inpatient unit- Psychiatry and Behavioral Medicine Unit (PBMU). I believe in delivering compassionate, evidence-based care in supporting patients and their families. My approach is both comprehensive and patient-centered, as it is important to consider the needs of the individual while also appreciating societal and cultural context. I specialize in working with diverse patient populations with various marginalized identities, such as those who identify as LGBTQ, gender diverse, and/or neurodiverse. I also work closely with the Adolescent Medicine Gender Clinic in supporting any mental health needs of transgender/gender diverse youth and their families. I also collaborate with colleagues in specialty medical clinics to coordinate care of medically complex patients. Additionally, I serve as a consultant with various school programs to support mental health initiatives and advocacy efforts.
Academically, I am involved with several initiatives both locally and nationally, particularly those that work to promote diversity and equity. I serve on committees supporting the SCH/UW CAP Fellowship Program, educating trainees and students through direct clinical supervision as well as with lectures and discussions. On a national level, I serve on the Sexual Orientation and Gender Identity Issues Committee (SOGIIC) for the American Academy of Child and Adolescent Psychiatry (AACAP). My clinical research focuses on finding strategies to better support the mental health and well-being of patients and families who are LGBTQ+. Additionally, I work on studies that explore the intersection between gender diversity and neuro diversity/autism spectrum.
I am a child and adolescent psychiatrist with experience in delivering evidence based care for youth with psychiatric disorders. My clinical work is primarily in the outpatient setting and I have experience with telehealth, community mental health, consultation to primary care and developing integrated care systems with pediatricians. I am a psychiatrist on the Partnership Access Line, which provides phone consultation regarding diagnosis and treatment to pediatricians and other primary care physicians throughout Washington, Wyoming and Alaska. I have worked as part of an integrated care team by providing consultation in person at Kent-Des Moines and Roosevelt clinics. I have expertise in the treatment of common childhood psychiatric disorders and I am particularly interested in treating anxiety and ADHD. I am also trained in cognitive behavioral therapy (CBT) and dialectical behavioral therapy (DBT) and incorporate this background in my work. I value working collaboratively with patients and their families to make a decision about treatment options based on the best evidence we have for safe and effective treatment.
Academically, I have enjoyed being part of the fellowship training program teaching about Integrated Care and currently co-chair the child and adolescent curriculum for the University of Washington Integrated Care Fellowship.
